NDC 65197-204
Emetrol Chewables
Sodium Citrate Dihydrate
Emetrol Chewables is a Oral Tablet, Chewable in the Human Otc Drug category. It is labeled and distributed by Wellspring Pharmaceutical Corporation. The primary component is Trisodium Citrate Dihydrate.
| Product ID | 65197-204_ed2d1f6e-58f2-4d42-916c-484dbe6fca8a |
| NDC | 65197-204 |
| Product Type | Human Otc Drug |
| Proprietary Name | Emetrol Chewables |
| Generic Name | Sodium Citrate Dihydrate |
| Dosage Form | Tablet, Chewable |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-03-15 |
| Marketing Category | UNAPPROVED DRUG OTHER / |
| Labeler Name | WellSpring Pharmaceutical Corporation |
| Substance Name | TRISODIUM CITRATE DIHYDRATE |
| Active Ingredient Strength | 230 mg/1 |
| Pharm Classes | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |